Loading...
Docoh
Log in Free sign up

Evolutionary Genomics (FNAM)

Company profile

Ticker
FNAM
Exchange
OTC
Employees
Incorporated
Nevada
Location
Colorado
Fiscal year end
Dec 31
Sector
Health Technology > Agriculture
Industry (SIC)
Services - Commercial Physical & Biological Research
PPD • IQVIA • PRA Health Sciences • Charles River Laboratories International • Syneos Health • Icon • Medpace • Incyte • Zymergen • SomaLogic ...
Former names
Fona, Inc.
SEC CIK
0000884363
Corporate docs
IRS number
264369698

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

8 Aug 22
9 Aug 22
31 Dec 22

Financial summary

Financial statements Chart FNAM financial data
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 897.78K 897.78K 897.78K 897.78K 897.78K 897.78K
Cash burn (monthly) 48.17K (no burn) 177.14K 238.9K 48.17K 134.31K
Cash used (since last report) 64.62K n/a 237.65K 320.49K 64.62K 180.18K
Cash remaining 833.16K n/a 660.13K 577.29K 833.16K 717.6K
Runway (months of cash) 17.3 n/a 3.7 2.4 17.3 5.3

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Recent insider trades

FNAM insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
23 May 22 Virginia P. Orndorff Common Stock Payment of exercise Dispose F No No 0.7 15,714 11K 123,490
23 May 22 Virginia P. Orndorff Common Stock Option exercise Acquire M No No 0.55 20,000 11K 123,490
23 May 22 Virginia P. Orndorff Stock Option Common Stock Option exercise Dispose M No No 0.55 20,000 11K 0
23 May 22 Steve B Warnecke Common Stock Payment of exercise Dispose F No No 0.7 52,381 36.67K 1,841,374
23 May 22 Steve B Warnecke Common Stock Option exercise Acquire M No No 0.55 66,667 36.67K 1,841,374
23 May 22 Steve B Warnecke Stock Option Common Stock Option exercise Dispose M No No 0.55 66,667 36.67K 0
23 May 22 Walter Messier Common Stock Payment of exercise Dispose F No No 0.7 78,571 55K 182,044
23 May 22 Walter Messier Common Stock Option exercise Acquire M No No 0.55 100,000 55K 182,044
23 May 22 Walter Messier Stock Option Common Stock Option exercise Dispose M No No 0.55 100,000 55K 0
25 Mar 22 Steve B Warnecke Stock Options Common Stock Grant Acquire A No No 0.825 133,333 110K 133,333
Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
8th grade Avg
New words: fully, lower, undergoing
Removed: clean, easier, efficient, faster, filing, receivable, routinely
From filing 10-Q 2022 Q2
Financial reports
View all
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
21 Mar 22
10-Q
2021 Q3
Quarterly report
1 Nov 21
10-Q
2021 Q2
Quarterly report
6 Aug 21
10-Q
2021 Q1
Quarterly report
13 May 21
10-K
2020 FY
Annual report
31 Mar 21
10-Q
2020 Q3
Quarterly report
13 Nov 20
10-Q
2020 Q2
Quarterly report
19 Aug 20
NT 10-Q
Notice of late quarterly filing
14 Aug 20
Current reports
View all
8-K
Unregistered Sales of Equity Securities
31 Mar 22
8-K
Changes in Registrant's Certifying Accountant
4 Oct 18
8-K
Other Events
21 May 18
8-K
Other Events
8 Sep 16
8-K
Unregistered Sales of Equity Securities
24 Feb 16
8-K
Completion of Acquisition or Disposition of Assets
22 Oct 15
8-K
Departure of Directors or Certain Officers
29 Sep 15
8-K/A
Entry into a Material Definitive Agreement
7 Oct 14
8-K
Entry into a Material Definitive Agreement
6 Oct 14
8-K
Entry into a Material Definitive Agreement
11 Jun 14
Registration and prospectus
D
Indefinite amount in equity, sold $1M, 17 investors
12 May 22
D
$1.05M in equity, sold $490K, 4 investors
15 May 19
D
$3.15M in equity, sold $2.88M, 25 investors
10 Mar 16
424B3
Prospectus supplement
10 Sep 15
S-4/A
Registration of securities issued in business combination transactions (amended)
27 Aug 15
S-4/A
Registration of securities issued in business combination transactions (amended)
29 Jul 15
S-4/A
Registration of securities issued in business combination transactions (amended)
1 Jul 15
S-4
Registration of securities issued in business combination transactions
1 Apr 15
10-12G
Registration of securities
22 Sep 10
Proxies
No filings
Other
View all
EFFECT
Notice of effectiveness
10 Sep 15
CORRESP
Correspondence with SEC
8 Sep 15
UPLOAD
Letter from SEC
20 Jul 15
CORRESP
Correspondence with SEC
5 Jul 15
UPLOAD
Letter from SEC
30 Apr 15
UPLOAD
Letter from SEC
1 Aug 13
CORRESP
Correspondence with SEC
18 Feb 13
UPLOAD
Letter from SEC
12 Nov 12
CORRESP
Correspondence with SEC
4 Nov 12
UPLOAD
Letter from SEC
13 Sep 12
Ownership
View all
4
EVOLUTIONARY GENOMICS / Walter Messier ownership change
25 May 22
4
EVOLUTIONARY GENOMICS / STEVE B WARNECKE ownership change
25 May 22
4
EVOLUTIONARY GENOMICS / Virginia P. Orndorff ownership change
25 May 22
4
EVOLUTIONARY GENOMICS / STEVE B WARNECKE ownership change
31 Mar 22
4
EVOLUTIONARY GENOMICS / STEVE B WARNECKE ownership change
21 May 21
4
EVOLUTIONARY GENOMICS / STEVE B WARNECKE ownership change
4 Jan 21
4
EVOLUTIONARY GENOMICS / Mark Virgil Boggess ownership change
29 Oct 19
4
EVOLUTIONARY GENOMICS / STEVE B WARNECKE ownership change
29 Oct 19
4
EVOLUTIONARY GENOMICS / Virginia P. Orndorff ownership change
29 Oct 19
4
EVOLUTIONARY GENOMICS / STEVE B WARNECKE ownership change
8 Sep 16